Correction to: Multi-center, randomized, double-blind, placebocontrolled study of quetiapine extended-release formulation in Japanese patients with bipolar depression

Murasaki, Mitsukuni; Koyama, Tsukasa; Kanba, Shigenobu; Takeuchi, Masahiro; Shimizu, Yuriko; Arita, Eri; Kuroishi, Kentaro; Takeuchi, Masahiro; Kamei, Shinya

doi:10.1007/s00213-018-5013-6

Correction to: Multi-center, randomized, double-blind, placebocontrolled study of quetiapine extended-release formulation in Japanese patients with bipolar depression

Correction
Published: 17 September 2018

Volume 235, pages 3079–3080, (2018)
Cite this article

Download PDF

Psychopharmacology Aims and scope Submit manuscript

Correction to: Multi-center, randomized, double-blind, placebocontrolled study of quetiapine extended-release formulation in Japanese patients with bipolar depression

Download PDF

Mitsukuni Murasaki¹,
Tsukasa Koyama²,
Shigenobu Kanba³,
Masahiro Takeuchi⁴,
Yuriko Shimizu⁵,
Eri Arita⁶,
Kentaro Kuroishi⁷,
Masahiro Takeuchi⁸ &
…
Shinya Kamei⁵

903 Accesses
1 Citation
Explore all metrics

The Original Article was published on 01 August 2018

Correction to: Psychopharmacology

https://doi.org/10.1007/s00213-018-4977-6

The original version of this article contained a mistake in Table 5. Correct version is presented here.

Table 5 Changes in clinical laboratory evaluations

Full size table

Author information

Authors and Affiliations

Institute of CNS Pharmacology, 3-14-20 Sagamiohno, Minami-ku, Sagamihara, Kanagawa, 252-0303, Japan
Mitsukuni Murasaki
Ohyachi Hospital, Clinical Research Center, 5-7-10 Ohyachi-higashi, Atsubetsu-ku, Sapporo, Hokkaido, 004-0041, Japan
Tsukasa Koyama
Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan
Shigenobu Kanba
Department of Clinical Medicine, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan
Masahiro Takeuchi
Japan/Asia Clinical Development 2, Astellas Pharma Inc., 2-5-1 Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8411, Japan
Yuriko Shimizu & Shinya Kamei
Global Clinical Science, Astellas Pharma Europe B.V, Sylviusweg 62, PO Box 344, 2300 AH, Leiden, The Netherlands
Eri Arita
Japan-Asia Data Science, Astellas Pharma Inc., 2-5-1 Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8411, Japan
Kentaro Kuroishi
Astellas Pharma Global Development, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA
Masahiro Takeuchi

Authors

Mitsukuni Murasaki
View author publications
You can also search for this author in PubMed Google Scholar
Tsukasa Koyama
View author publications
You can also search for this author in PubMed Google Scholar
Shigenobu Kanba
View author publications
You can also search for this author in PubMed Google Scholar
Masahiro Takeuchi
View author publications
You can also search for this author in PubMed Google Scholar
Yuriko Shimizu
View author publications
You can also search for this author in PubMed Google Scholar
Eri Arita
View author publications
You can also search for this author in PubMed Google Scholar
Kentaro Kuroishi
View author publications
You can also search for this author in PubMed Google Scholar
Masahiro Takeuchi
View author publications
You can also search for this author in PubMed Google Scholar
Shinya Kamei
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shinya Kamei.

Additional information

The online version of the original article can be found at https://doi.org/10.1007/s00213-018-4977-6

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murasaki, M., Koyama, T., Kanba, S. et al. Correction to: Multi-center, randomized, double-blind, placebocontrolled study of quetiapine extended-release formulation in Japanese patients with bipolar depression. Psychopharmacology 235, 3079–3080 (2018). https://doi.org/10.1007/s00213-018-5013-6

Download citation

Published: 17 September 2018
Issue Date: October 2018
DOI: https://doi.org/10.1007/s00213-018-5013-6

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Correction to: Multi-center, randomized, double-blind, placebocontrolled study of quetiapine extended-release formulation in Japanese patients with bipolar depression

Author information

Authors and Affiliations

Corresponding author

Additional information

Rights and permissions

About this article

Cite this article

Share this article

Search

Navigation